Company news
Sanuwave Health, Inc. (NASDAQ:SNWV) news
Every Sanuwave Health, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Sanuwave Announces Q2 FY2026 Financial Results
August 6, 2026
Sanuwave Will Host a Conference Call on August 7, 2026 at 8:30 AM (ET) to Present Q2 2026 Financial Results
July 30, 2026
Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6–$9.8 Million, Above High End of Revised Guidance
July 13, 2026
Sanuwave Health Updates Second Quarter 2026 Guidance
June 16, 2026
Sanuwave Announces Revenues and Financial Results for Q1 FY2026
May 12, 2026
Sanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial Results
May 6, 2026
Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6–$9.7 Million, Up 3-4% Year-over-Year
April 16, 2026
Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025
March 26, 2026
Sanuwave Will Host a Conference Call on March 27, 2026 at 8:30 AM (ET) to Present Q4 and Full Year 2025 Financial Results
March 20, 2026
Sanuwave Health Announces Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Ful...
January 9, 2026
Sanuwave to Participate in the 44th Annual J.P. Morgan Healthcare Conference
December 10, 2025
Sanuwave Announces the Addition of UltraMIST to Healogics Group Purchasing Organization (GPO), iSupply
December 8, 2025
Sanuwave Announces Q3 FY2025 Financial Results
November 7, 2025
Sanuwave Will Host a Conference Call on November 7, 2025 at 8:30 AM (ET) to Present Q3 2025 Financial Results
November 3, 2025
Sanuwave Health Announces Preliminary Revenue Results for the Third Quarter 2025 (Ended September 30, 2025)
October 6, 2025
Sanuwave Announces Strategic Debt Refinancing with New Credit Facility
September 26, 2025
Sanuwave Announces Q2 FY2025 Financial Results
August 8, 2025
Sanuwave Will Host a Conference Call on August 8, 2025 at 8:30 AM (ET) to Present Q2 2025 Financial Results
August 4, 2025
Sanuwave Health to Present at Canaccord Genuity Growth Conference
July 22, 2025
Sanuwave Health Announces Preliminary Revenue Results for the Second Quarter 2025 (Ended June 30, 2025)
July 14, 2025
Sanuwave Health Appoints Industry Veteran Dustin Libby as Executive Vice President of Commercial Operations
June 3, 2025
Sanuwave Health Selected for Inclusion in Russell 2000® Index
May 28, 2025
Sanuwave Health Appoints Greg Bazar to Board of Directors
May 28, 2025
Sanuwave Announces Q1 FY2025 Financial Results
May 9, 2025
Sanuwave Will Host a Conference Call on May 9, 2025 at 8:30 AM (ET) to Present Q1 2025 Financial Results
May 5, 2025
SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2025 (Ended March 31, 2025)
April 8, 2025
SANUWAVE Announces Record Quarterly Revenues: Q4 FY2024 Financial Results
March 21, 2025
SANUWAVE Will Host a Conference Call on March 21, 2025 at 8:30 AM (ET) to Present Q4 and Full Year 2024 Financial Results
March 17, 2025
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering
October 18, 2024
SANUWAVE Health Announces 1-For-375 Reverse Stock Split
October 16, 2024
SANUWAVE Announces Record Quarterly Revenues: Q2 FY2024 Financial Results
August 13, 2024
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results
August 7, 2024
SANUWAVE Health Announces Preliminary Revenue Results for the Second Quarter 2024 (Ended June 30, 2024)
July 10, 2024
SANUWAVE Announces Termination of Merger Agreement With SEP Acquisition Corp.
June 26, 2024
SANUWAVE Provides Corporate Update
June 4, 2024
SANUWAVE Will Host a Conference Call on June 4, 2024 at 8:30 AM (ET) to Provide a Corporate Update
June 3, 2024
SANUWAVE Announces Q1 FY2024 Financial Results
May 10, 2024
SANUWAVE Will Host a Conference Call on May 10, 2024 at 8:30 AM (ET) to Present Q1 Financial Results
May 7, 2024
SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024)
April 10, 2024
SANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial Officer
April 1, 2024
SANUWAVE Announces Record Q4 and FY2023 Revenue
March 22, 2024
SANUWAVE Will Host a Conference Call on March 22, 2024 at 8:30 AM (ET) to Present the Q4 and FY2023 Financial Results
March 20, 2024
SANUWAVE Health Reports Stockholder Approval of SEPA Merger at Special Meeting of Stockholders
February 22, 2024
SANUWAVE Announces Special Meeting of Stockholders to Vote on Business Combination with SEP Acquisition Corp. (Nasdaq: SEPA)
January 22, 2024
SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter and Fiscal Year 2023, Ended December 31, 2023
January 10, 2024
SANUWAVE Announces Q3 2023 Financial Results
November 10, 2023
SANUWAVE Will Host a Conference Call on November 10, 2023 at 8:00 AM (ET) to Present the Q3 2023 Financial Results
November 8, 2023
SANUWAVE Health Announces Preliminary Revenue Results for the Third Quarter Ended September 30, 2023
October 10, 2023
SANUWAVE Health, Inc., a Leading Provider of FDA Approved Next-Generation Wound Care Products, Enters into a Merger Agreement with Sweat ...
August 23, 2023
SANUWAVE Announces Q2 2023 Financial Results
August 11, 2023